In compliance with Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and as informed by the Registrar and Transfer Agent, Mercury Laboratories has informed that the duplicate share certificate(s) in lieu of original share certificate(s) have been issued to the shareholders, as details enclosed. Pursuant to the SEBI circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022 a letter of confirmation will be issued to the securities holder/claimant upon completion of necessary procedure regarding duplicate share certificates.
The above information is a part of company’s filings submitted to BSE.
